Hint mode is switched on Switch off
For swift navigation between sections

Nextgen
TIN 9729340241, PSRN 1237700119854

PDF download

Choose all Reset all
Download Cancel
Organization name
Nextgen Joint-Stock Company
Country name
Russia
Country of registration
Russia
Industry
Medical Devices
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Unlock data Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Nextgen is a subsidiary of Artgen, a resident of the Lomonosov Innovation and Technology Center (INTC) and Medtech. The company specializes in the development and implementation of gene therapy drugs, with a focus on expanding the indications for Neovasculgen, the world’s first registered gene therapy drug for treating lower limb ischemia.

Awards

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • TIN
    9729340241
  • NACE
    *** ***
  • NAICS
    *** ***
  • IEC
    772901001
  • PSRN
    1237700119854 on 13/02/2023
  • OKPO
    80937181
Registration is required to get access.